rdf:type |
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0007131,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0045093,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0210657,
umls-concept:C0282460,
umls-concept:C1514162,
umls-concept:C1705294
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-4-5
|
pubmed:abstractText |
This randomized phase II trial evaluated single-agent pemetrexed or sequential pemetrexed/gemcitabine in patients with non-small cell lung cancer (NSCLC) who were elderly (> or = 70 years) or younger than 70 years and ineligible for platinum-based chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1556-1380
|
pubmed:author |
pubmed-author:CaffoOrazioO,
pubmed-author:FavarettoAdolfoA,
pubmed-author:GregorcVanessaV,
pubmed-author:GridelliCesareC,
pubmed-author:KaukelEckhardE,
pubmed-author:MüllerThomas RTR,
pubmed-author:ManegoldChristianC,
pubmed-author:MartoniAndreaA,
pubmed-author:MigliorinoMaria RitaMR,
pubmed-author:MuñozMaríaM,
pubmed-author:PetersonPatrickP,
pubmed-author:ReckMartinM,
pubmed-author:RossiAntonioA,
pubmed-author:RussoFrancescaF,
pubmed-author:SchmittelAlexanderA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-9
|
pubmed:dateRevised |
2008-5-6
|
pubmed:meshHeading |
pubmed-meshheading:17410045-Aged,
pubmed-meshheading:17410045-Aged, 80 and over,
pubmed-meshheading:17410045-Antineoplastic Agents,
pubmed-meshheading:17410045-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17410045-Deoxycytidine,
pubmed-meshheading:17410045-Female,
pubmed-meshheading:17410045-Glutamates,
pubmed-meshheading:17410045-Guanine,
pubmed-meshheading:17410045-Humans,
pubmed-meshheading:17410045-Lung Neoplasms,
pubmed-meshheading:17410045-Male,
pubmed-meshheading:17410045-Middle Aged,
pubmed-meshheading:17410045-Neoplasm Staging
|
pubmed:year |
2007
|
pubmed:articleTitle |
Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.
|
pubmed:affiliation |
Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy. cgridelli@libero.it
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|